Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Zhejiang University
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Cedars-Sinai Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Jonsson Comprehensive Cancer Center
University of South Florida